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Abstract
Aims: Because hepatic cancer stem cells (HCSCs) are believed to derive from the conversion of hepatic normal stem cells
(HNSCs), the identification of the differences that distinguish HCSCs from HNSCs is important.
Methods: The HCC model was established in F344 rats by DEN induction. Using FACS analysis, side population cells from
HCC (SP-HCCs) were isolated from the epithelial-like cells of HCC tissues, and the side population cells from normal liver (SP-
NLCs) were isolated from syngeneic normal liver cells. The expression of stem cell markers was detected in both freshly
isolated and amplified subpopulations. After induction with HGF, the differentiation of each subpopulation was analyzed by
detection of early and late liver markers. In vivo, the biological characteristics of SP-HCCs and SP-NLCs were analyzed by
repairing injured livers or forming tumors in nude mice. In addition, the expression of miRNAs was examined in both
populations by miRNA array and QRT-PCR.
Results: SP-NLCs and SP-HCCs were 4.3060.011% and 2.10060.010% of the whole population, respectively. Both SP-NLCs
and SP-HCCs displayed greater expression of stem cell markers (CD133 and EpCAM) than NSP-NLCs and NSP-HCCs,
respectively (P,0.01), both after fresh isolation and amplification. Upon HGF induction, SP-NLCs generated many ALB
positive cells and few CK-7 positive cells, but NSP-NLCs could generate only ALB positive cells. In contrast, SP-HCCs gave rise
to only AFP positive cells. As few as 5610
5 SP-NLCs were capable of repairing liver injury, while the same number of NSP-
NLCs could not repair the liver. Furthermore, only 1610
4 SP-HCCs were necessary to initiate a tumor, while NSP-HCCs could
not form a tumor. Compared to SP-NLCs, 68 up-regulated and 10 down-regulated miRNAs were present in SP-HCCs
(P,0.01).
Conclusion: Based on the decisive roles of some miRNAs in the genesis of HCSCs, miRNAs may contribute to the different
characteristics that distinguish SP-HCCs from SP-NLCs.
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Introduction
Increasing evidence has shown that cancers contain a small
subset of their own stem-like cells, called ‘‘cancer stem cells’’
(CSCs) [1,2,3], which are mostly affected by both tumor
suppressors and cancer inducers [4,5,6]. HCC also contains
hepatic CSCs (HCSCs), which have the greatest potential to
proliferate and invade surrounding tissue [7]. Recent publications
have shown that HCSCs may originate from hepatic normal stem
cells (HNSCs) [8]. Even the initial event that transforms HNSCs to
HCSCs is proposed to be a form of deregulation of HNSCs self-
renewal [9]. Thus, comparing the characteristics of HNSCs and
HCSCs is important. Normal liver is rich in HNSCs [10], and the
suggestion that these HNSCs may serve as an optimal control for
studying the characteristics of HCSCs is reasonable. However,
molecular markers that define both HCSCs and HNSCs remain
controversial; therefore, the isolation of side population (SP) cells
has been widely used to enrich both types of stem cells [11]. SP
cells have been demonstrated to be immature and undifferentiated
cells and to express high levels of some specific stem cell markers
[12]. Hence, the isolation of SP cells is an alternative source of
stem cells, which is particularly useful in situations in which stem
cell markers are unknown [12]. In mice and rats, the SP
phenotype appears to be a common feature of stem cells, including
normal and cancer stem cells [13,14,15]. In the liver, these SP cells
have been shown to serve a central role in liver regeneration and
liver cancer [16]. Therefore, SP cells can be considered
appropriate alternatives to study HNSCs and HCSCs.
MiRNAs are emerging as important regulators of post-
transcriptional gene regulation. The importance of miRNAs is
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23311underscored by the fact that they are often deregulated during
carcinogenesis [17,18,19,20]. Some miRNAs can promote tumor
growth through common mechanisms that contribute to miRNA-
regulated cell cycle control [21]. In addition, miRNAs have been
demonstrated to be an integral component of stem cell regulation,
including normal stem cells (NSCs) and CSCs [22]. A perturbation
of key miRNA-mRNA networks in NSCs has been suggested to be
a hallmark of CSCs [23]. In fact, a single oncogene (miRNA-145)
has been demonstrated to re-program primary cells to display a
CSCs phenotype [24]. Thus, the identification of common and
unique expression patterns of miRNAs between HCSCs and
HNSCs is essential.
In this study, we applied SP analysis to two different populations
of primary cultured epithelial cells. One cell type was isolated from
rat HCC tissues induced by diethylinitrosamine (DEN) and the
other cell type was isolated from syngeneic rat liver tissues. Side
populations from normal liver cells (SP-NLCs) and from HCCs
(SP-HCCs) highly expressed stem cell markers. In vitro, both SP
cells had high capacities to proliferate and could differentiate into
mature cells upon induction with hepatocyte growth factor (HGF).
In vivo, SP-NLCs could greatly aid in repairing an injured rat liver.
In contrast, SP-HCCs could initiate tumors both in subcutaneous
and liver tissues of Non-obese diabetic/severe combined immu-
nodeficiency (NOD/SCID) mice. Assuming that these differences
were related to the vastly different expression patterns of miRNAs
between these two cell populations, we examined the miRNA
profiles of SP-NLCs and SP-HCCs. Because HCSCs are proposed
to be HCC initiating cells, identifying the differences between SP-
HCCs and SP-NLCs, including deregulated miRNAs, may greatly
aid in understanding the genesis of HCSCs and the tumorigenesis
of HCC.
Materials and Methods
1. Specimen collection
Thirty male Fisher 344 rats (from the National Rodent
Laboratory Animal Resource, Shanghai, China) were randomly
divided into control and trial groups. Rats in the trial group were
treated with 0.05% DEN (Sigma Co, USA) in their drinking water
for 6 weeks and were then changed to normal drinking water [25],
whereas rats in the control group were given a normal diet. Three
rats from each group were sacrificed under anesthesia at 2, 6, 10,
14 and 18 weeks after DEN induction. Both HCC nodules from
the trial group and normal livers from the control group were
collected. Portions of these tissues were fixed in 10% phosphate-
buffered neutral formalin and routinely processed and stained with
Hematoxylin and Eosin (H&E) for histological examination. The
remaining tissues were used directly in the experiments detailed
below. All animal experiments were performed in accordance with
animal study protocols [26] and approved by the Research Animal
Care and Use Committee at the Fourth Military Medical
University. The animal protocol number was SYXK2008-005.
2. Cell isolation and culture
Hepatic cancer cells (HCCs) were isolated according to Hohne
et al. [27] with minor modifications, and normal liver cells (NLCs)
were isolated according to Oertel et al. [28]. Both HCC and
normal liver (NL) tissues were minced in Dulbecco’s modified
eagle’s medium (DMEM) (Invitrogen Co, USA) with 0.1%
collagenase type IV and 0.005% trypsin (Sigma Co, USA) and
then incubated for 20 min at 37uC in a shaking water bath. After
incubation, supernatants containing the released cells were passed
through a 100 mm nylon mesh and centrifuged at 1,0006 g for
8 min. The pellets were washed twice with phosphate-balanced
saline (PBS) (Invitrogen Co, USA), and single cell suspensions were
collected. The NL single cell suspension was centrifuged for 5 min
at 1006g in DMEM, and the supernatant was collected. A Percoll
(Invitrogen Co, USA) gradient was prepared in a 50 ml tube by
sequentially layering 10 ml of 70%, 50% and 30% Percoll. A total
of 20 ml of NLCs in PBS was added, and the tube was centrifuged
at 10006g for 10 min. The cell fraction at the interface between
30% and 50% Percoll was collected. Both NLCs and HCCs were
cultured in 6-well plates containing William’s E Medium (Sigma
Co, USA) supplemented with 10% vol/vol fetal bovine serum
(Invitrogen Co, USA), 5 mg/ml insulin (Sigma Co, USA), 5 mM
hydrocortisone, 100 U/ml penicillin and 100 mg/ml streptomycin
at 37uC in a humidified atmosphere of 5% CO2. Adherent cells
proliferated and extended as a monolayer colony after 20 days in
culture. We collected the monoclonal cell population by local
digestion with cloning cylinders and transferred the cells into a
new culture dish to continue the culturing process.
3. SP Cell sorting
The cells were divided into two portions: half was directly used
as a sham sorted population (SSP), while the other half was used
for cell sorting on a FACS Vantage II cell sorter (Becton Dickinson
Co, USA). The following information describes our isolation
protocol. Cells were labeled with Hoechst 33342 dye (Sigma Co,
USA) at a final concentration of 4 mg/ml in the presence or
absence of 50 mM verapamil (Sigma Co, USA) and incubated at
37uC for 90 min according to the methods described by Goodell et
al. [11]. The stained cells were washed with ice-cold PBS
containing 2% bovine serum albumin (BSA) and 10 mM HEPES,
centrifuged at 4uC and resuspended in the same buffer. Propidium
iodide (PI) (Sigma Co, USA) was used to detect cell viability.
Hoechst 33342 was excited at 355 nm and its fluorescence was
analyzed at two wavelengths: Hoechst 33342 blue at 450 nm and
Hoechst 33342 red at 675 nm. A second 488 nm argon laser
(100 mW) was used to excite PI fluorescence for excluding dead
cells. SP cells showed low staining with Hoechst and non-side
population (NSP) cells were more brightly stained.
4. Cell growth test
This experiment was employed to evaluate the proliferative ability
of the cells from each subpopulation, including SP, NSP and SSP. The
cells in each subpopulation were adjusted to 2610
6/ml and seeded in
32 flasks (0.5610
5 cells per flask). The culture media was
supplemented with leukemia inhibitory factor (LIF) at a concentration
of 10 mg/ml. Every day during a period of 7 days, 4 parallel cell
samples from each subpopulation were trypsinized and counted under
an inverted microscope (BX50-32E01, Olympus, Tokyo, Japan).
5. Detection of stem cell markers by fluorescent activated
cells sorting (FACS)
The expression of stem cell markers was analyzed by a
FACSCaliburTM system (BD Immunocytometry Systems, San Jose,
CA) in both freshly isolated subpopulations and amplified subpopu-
lations. Briefly, the cells were incubated in William’s E Medium
(containing 20% FBS) at 10
6 cells/ml for 15–30 min at room
temperature to block non-specific sites for antibody binding. The cells
from different subpopulations were washed twice with PBS and re-
suspended in 990 ml PBS. Subsequently, 10 ml of antibodies, including
CD133 (PE conjugated, Biolegend, USA) and EpCAM (fluorescein
isothiocyanate (FITC) conjugated, Biolegend, USA), were added to
each cell suspension. After 30 min of incubation at 4uCi nt h ed a r k ,t h e
cells were washed twice with PBS, fixed in 0.1% formaldehyde and
analyzed by flow cytometry.
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The cells from each subpopulation were cultured in induction
media, which was commercial serum-free medium (Sigma Co,
USA) supplemented with HGF (20 ng/ml). The cell differentiation
was evaluated by detecting the expression of liver-specific markers
as described below.
7. Detection of liver markers by immunofluorescence (IF)
After induction by HGF, IF was performed to qualitatively
evaluate whether the induced cells expressed specific liver markers.
To identify bi-directional differentiation of the different populations
in NLCs (SP-NLCs, NSP-NLCs and SSP-NLCs), two specific
primary markers were selected: the mature hepatic marker albumin
(ALB) (dilution 1:200; Santa Cruz, CA) and the biliary marker
cytokine 7 (CK-7) (dilution 1:200; Santa Cruz, CA). To identify
maturation of different populations in HCCs (SP-HCCs, NSP-
HCCs and SSP-HCCs), the tumor markers alpha fetoprotein (AFP)
(dilution 1:200; Santa Cruz, CA) and CK-19 (dilution 1:200; Santa
Cruz, CA) were selected. Briefly, with the culture medium removed,
cells on the culture slide were rinsed twice with PBS, fixed with 4%
paraformaldehyde for 20 min and then immersed in PBS for
10 min, followed by exposure to 0.01% Triton X-100 at room
temperature for 10 min. For blocking non-specific immune
reactions, the cells were treated with 6% goat serum (Santa Cruz,
CA) at room temperaturefor 30 min. Thecells culturedineach slide
were subjected to primary antibodies at 4uC overnight and were
washedthreetimeswithcoldPBS.ThefluorescentFITC-conjugated
goatanti-rabbitsecondaryantibody(dilution1:100;SantaCruz,CA)
was added and incubated for 2 h. Subsequently, the cells were
treated with 2-(4-Amidinophenyl)-6-indolecarbamidine dihydro-
chloride(DAPI)(dilution1:100;Sigma)for15 min.Thefluorescence
was observed through an appropriate filter using a fluorescence
microscope (FV1000MPE, Olympus Co, Tokyo, Japan).
8. Detection of liver markers by western blotting
After induction by HGF, western blotting was performed to
quantitatively detect specific liver markers in the induced cells. ALB
andCK-7wereexamined inSP-NLCs, NSP-NLCs andSSP-NLCs;
AFP and CK-19 were analyzed in SP-HCCs, NSP-HCCs and SSP-
HCCs.Cellswerelysedinwhole-cellextraction buffer(RIPAbuffer)
containing a protease inhibitor cocktail tablet (Complete-Mini,
Roche Diagnostics, Mannheim, Germany). The homogenates were
centrifuged at 30006 g for 20 min at 4uC, and the supernatants
were collected. Proteins were separated on 12% SDS-polyacryl-
amide gel and transferred to an Immobilon-P PVDF (polyvinyli-
dene fluoride) membrane (MILLIPORE, Billerica, MA, USA). The
blots were saturated with blocking buffer (5% skim milk in TBS-T)
for 1 h at room temperature and then incubated overnight at 4uC
with rabbit anti-human/rat/mouse monoclonal antibodies (1:600;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and a
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody
(1:600; Sigma, Saint Louis, MO). After washed in TBS-T, the
membraneswereincubatedfor1 hatroomtemperaturewithHRP-
Goat Anti-Rabbit IgG (1:2000; Perkin Elmer, Inc., Waltham, MA).
Detection of the proteins was performed using an ECL system (Cell
Signaling Technology, Beverly, MA, USA). The grayscale values of
each band on the blots were measured using BandScan4.3.
9. Liver injury model and cell transplantation
SP-NLCs and NSP-NLCs were independently washed with PBS
in the dark and resuspended in 2 ml staining solution to label the
cell membrane with red fluorescence at 37uC, according to the
protocol supplied with the PKH26 red fluorescent cell linker kit
(Sigma Corp., USA). Serum-containing media was added to the
staining solution to terminate the staining 5 min later. Stained cells
were washed three times with PBS and suspended in 0.5 ml PBS
for transplantation. To induce liver injury, 20 normal F344 rats
(10 for SP-NLCs transplantation, 10 for NSP-NLCs injection)
were administered CCl4 intraperitoneally at a dose of 1.2 ml/kg
body weight and received a two-thirds partial hepatectomy (2/3
PH) three days later. Immediately after PH, the prepared cells
(5610
5 cells per rat) were separately injected into these rats
through the portal vein.
For each liver, we randomly cut four frozen sections. To
evaluate the colonization effects of SP-NLCs and NSP-NLCs, the
restored liver sections were viewed under an inverted microscope.
When red areas were observed in the sections, the result was
identified as positive. Under each field of view, the positive areas
were counted, and the percentage of the positive area relative to
the whole area was calculated. A percent of red area of ,5% was
defined as negative (2), 5–25% as positive (+), 25–50% as
moderately positive (++) and .50% as strongly positive (+++).
10. NOD/SCID xenograft transplant experiments
Different numbers (1610
7,1 610
6,1 610
5 and 1610
4) of SP-
HCCs or NSP-HCCs were injected into NOD/SCID mice by
subcutaneous injection. Each group contained 4 mice; thus, 32
mice were used for xenotransplantation. Each mouce were done
with 4 injections, symmetrically 2 injections in left back and 2
injections in right back. Tumor growth was monitored every 2
days after the second week of inoculation. All mice were sacrificed
at day 60. All of the tumor tissues were collected, fixed in 4%
formaldehyde, and embedded in paraffin for H&E staining to
assess tumor histology. All the results were judged by three
different researchers independently. We summarized the data and
calculated the average diameter of tumors in each group (such as
1610
7 SP-HCCs group). According to the average size of tumors,
they were divided into four different grades: grade 1 (2), no
macroscopic tumor; grade 2 (+), the diameter of tumor ,0.2 cm;
grade 3 (++), 0.2–0.5 cm; grade 4 (+++), .0.5 cm.
11. The expression of miRNAs in SP cells
Total RNAs were obtained from both SP-NLCs and SP-HCCs
by the Totally RNA isolation kit (Ambion, Austin, TX). The
quality and quantity of total RNAs were checked by 1.5% agarose
gel electrophoresis and ultraviolet quantitation. The expression
profiles of miRNAs were then detected by the miRCURY LNA
TM
(locked nucleic acid) microRNA Arrays Kit (Exiqon Co, Den-
mark), which covers all human, mouse and rat miRNA antisense
sequences. In addition, the kit also incorporated 144 miRPlus
TM
probes, which were provided by Exiqon Corporation for novel
miRNA detection. One microgram of RNA from SP-HCCs, SP-
NLCs and reference pools were co-hybridized onto the Exiqon
miRNA Array for 16 hr at 56uC. After incubation with Cy3-
labeled dendrimers (Genisphere Inc, Hatfield, PA) [29], the
microarrays were washed consecutively with wash buffers A, B and
C. The fluorescent signals on the hybridized array were captured
by a GenePix 4000B scanner and quantified using GenePix Pro4.0
(Axon Instruments, Burlingame, CA). Data manipulation was
facilitated with Normalization Suite v1.63 (Ontario Cancer
Institute, Toronto, Canada) [30]. The test to reference ratio for
each miRNA was averaged from triplicate spots and between
replicate experiments. Ratios greater or less than two-fold were
considered to be up-regulated or down-regulated, respectively.
Two highly up-regulated miRNAs, three slightly up-regulated
miRNAs, one greatly down-regulated miRNA and one moderately
down-regulated miRNA were selected as representative miRNAs
Hepatic Normal and Cancer Stem Cells
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23311to be validated by quantitative real time polymerase chain reaction
(QRT-PCR). Total RNAs were reverse-transcribed by Multi-
Scribe (Applied Biosystems) in reaction mixtures containing miR-
specific stem-loop reverse-transcription (RT) primers (Table 1).
The PCR primers are listed in Table 1, and the cycle parameters
for the PCR reaction were 95uC for 15 min followed by 40 cycles
of a denaturation step at 95uC for 15 sec and an annealing/
extension step at 60uC for 60 sec. All reactions were run in
triplicate. The relative amount of each miRNA to U6 RNA was
described by the equation DCT=(C TmiRNA2CTU6) [31]. The
fold change in miRNAs from SP-HCCs compared with SP-NLCs
are shown using the equation 2
2DDCT, where DDCT=(DCT SP-
HCCs2DCT SP-NLCs).
12. Targets of deregulated miRNAs
12.1. Prediction of potential targets for deregulated
miRNAs. The potential targets for the deregulated miRNAs
found by the above methods were predicted by two publicly
available algorithms, including MiRBase Targets version 5
(available at: http://microrna.sanger.ac.uk/) and Targetscan
version 4.2 (http://www.targetscan.org/).
12.2 Identification of targets by semi-quantitative real
time polymerase chain reaction (sQRT-PCR). We
summarized the proven targets of seven validated deregulated
miRNAs. Among these targets, the miR-200a* target genes ZEB1
and ZEB2 [32,33] were analyzed in both SP-HCCs and SP-NLCs
by sQRT-PCR. Total RNA was extracted from cells using Trizol
reagent (Molecular Research Center, Cincinnati, OH), and
reverse transcribed into cDNA by SuperScript II Reverse
Transcriptase according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA). Equal amounts of cDNA from these
two samples were amplified with the following specific primers:
ZEB1 (Sense 59- AAGAAAGTGTTACAGATGCAGCTG-39,
Antisense 59- CCCTGGTAACACTGTCTGGTC-39); and
ZEB2 (Sense 59-ATACCAGCGGAAACAAGGATTTCA-39,
Antisense 59-CAGGAATCGGAGTCTGTCAAGTCA-39). The
number of PCR cycles was 35. Each cycle consisted of
denaturation step at 95uC for 30 s, primer annealing step at
65uC for 30 s and extension step at 72uC for 45 s. The PCR
products were analyzed by 1.5% agarose gel electrophoresis
stained with ethidium bromide.
13. Statistical analyses
Data are expressed as the mean 6 standard error from at least
three separate experiments performed in triplicate. Differences
between groups were analyzed with SAM software version 3.0
using a double-sided Student’s t-test when only two groups were
present, and the null hypothesis was rejected at the 0.05 level.
Results
1. Tissues preparation and cell culture
NL tissues obtained from the control group were bright red and
displayed smooth surfaces (Figure 1A-i). When these livers were
cut into thin sections, completely normal liver tissue was revealed
(Figure 1A-ii). Upon H&E staining, the liver lobules were observed
to be in good order (Figure 1A-iii). Small NLCs were selected by
Percoll discontinuous gradient centrifugation (PDGC) and cul-
tured. NLCs formed clones after approximately 8 days of culture
(Figure 1A-iv). After culturing for 15 days, these small cells covered
approximately 65% of the plate (Figure 1A-v). After 25 days, these
homogeneous cells almost fully covered the plates (Figure 1A-vi).
Small tumors were first found in rats sacrificed 8 weeks after
DEN induction. After another 10 weeks, two-thirds of the livers
contained tumor tissues with rough surfaces (Figure 1B-i). We also
found numerous metastatic cancer nodules in the lungs (Figure 1B-
ii). Three different pathologists assessed the H&E staining and
verified that these neoplasms were all of hepatic origin (Figure 1B-
iii). The cells isolated from the primary HCC tissues grew slowly at
first with only a few clones formed (Figure 1B-iv). After 15 days,
the cells proliferated rapidly and covered 60% of each plate
(Figure 1B-v). One month later, these cells fully covered the plates
(Figure 1B-vi).
2. Isolation of SP cells by FACS
In the NLCs group, the percentage of SP cells was
4.300%60.011% (Figure 1C-i). When exclusion of the dye was
inhibited by verapamil in the control group, SP cells were nearly
identical to the rest of the cells (Figure 1C-ii). The percentage of
SP cells in the HCCs group was 2.100%60.010% (Figure 1C-iii).
When the exclusion of the dye was inhibited by verapamil, these
SP cells also could not be discriminated from their controls
(Figure 1C-iv). The profile of SP cells in NLCs was significantly
higher than that in HCCs (P,0.05) (Figure 1C-v).
3. Self-renewal of SP cells
Two standard features are characteristics of stem cells: self-
renewal and multipotency. For self-renewal, SP-HCCs proliferated
the fastest during 7 days culture, followed by SP-NLCs, SSP-
HCCs, SSP-NLCs and NSP-HCCs (which proliferated similarly),
Table 1. Oligonucleotides used in the QRT- PCR.
Name RT primer (59-39) PCR Forward primer (59-39)
Tm
(6C)
U6 CGCTTCACGAATTTGCGTGTCAT GCTTCGGCAGCACATATACTAAAAT 60
has-miR-10b GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACAAA CATGGTACCCTGTAGAACCGAA 60
has-miR-21 GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCAACA CGCGCTAGCTTATCAGACTGA 60
hsa-miR-34c-3p GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCTGGC GGTGGAATCACTAACCACACG 60
hsa-miR-16 GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGCCAA CGCGCTAGCAGCACGTAAATA 60
has-let7i* GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCAAG TAGTACTGCGCAAGCTACTGC 60
has-miR-200a* GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCCAGC GAGTGCATCTTACCGGACAGT 60
has-miR-148b* GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGCCTGA GGCGCAAGTTCTGTTATACAC 60
General primer PCR Reverse Primer: GTGCAGGGTCCGAGGT 60
doi:10.1371/journal.pone.0023311.t001
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cells proliferated much faster than both NSP cells and SSP cells
(P,0.01), and HCCs proliferated a little faster than NLCs.
Because the initial number of each cell population was the same,
totally different cell numbers were present in each group at the end
of the culture period (Figure 2B). SP cells (Figure 2B-i,iv) were
found to be more homogeneous and much smaller in size than
both NSP cells (Figure 2B-ii,v) and SSP cells (Figure 2B-iii,vi)
(P,0.01). However, no significant morphological differences were
observed between SP-NLCs (Figure 2B-i) and SP-HCCs
(Figure 2B-iv). Thus, these two populations could not be
discriminated from each other under an inverted microscope.
At the very beginning of culture, both SP-NLCs and SP-HCCs
expressed more of the stem cell markers than NSP-NLCs and
NSP-HCCs, respectively (P,0.01) (Figure 2C). The following
percentages of positive cells in each subpopulation were observed:
CD133 percentages in SP-NLCs, NSP-NLCs, SSP-NLCs, SP-
HCCs, NSP-HCCs and SSP-HCCs were 81.267.08, 11.461.31,
30.363.21, 86.768.32, 12.761.39 and 31.663.42, respectively;
EpCAM percentages in these subpopulations were 80.168.10,
10.661.21, 31.263.18, 86.563.28, 12.461.31 and 32.663.67,
respectively. At the end of the culture period, SP-NLCs and SP-
HCCs still expressed more of the stem cell markers than NSP-
NLCs and NSP-HCCs, respectively (P,0.01) (Figure 2D). Fur-
Figure 2. The self-renewal analysis of each subpopulation. (A) The cell growth curve during 7 days culture. (B) After amplification, distinct cell
densities were observed in the different subpopulations. (C) The expression of stem cell markers (CD133 and EpCAM) was different in each freshly
isolated and amplified subpopulation by FACS. (D) The exact data were reflected by a column chart. CD133/EpCAM-Fresh indicates the expression of
CD133/EpCAM in freshly isolated subpopulations, and CD133/EpCAM-Amplified means the expression of CD133/EpCAM in amplified subpopulations.
Original magnification, 1006(B).
doi:10.1371/journal.pone.0023311.g002
Figure 1. Upper panel: normal liver segregation and cell culture. (A-i) Morphology of livers in the non-DEN treated group, (A-ii) Thin-sliced
sections reveal completely normal liver tissue, (A-iii) Histological features of normal liver with a regular structure. Primary cultured NLCs for (A-iv) 4
days, (A-v) 15 days and (A-vi) 25 days. Middle panel: primary HCC tissue segregation and cell culture. (B-i) Multiple primary HCC nodules in the rat
liver, one of which is indicated by an arrow, (B-ii) Metastatic HCC nodules in rat lungs, which are indicated by arrows, (B-iii) Histological features of
metastatic HCC tissue, in which normal lung lobules were replaced by carcinoma masses; Primary cultured HCC cells for (B-iv) 4 days, (B-v) 15 days
and (B-vi) 30 days. Lower panel: the isolation of different subpopulations. (C-i) Without verapamil: SP cells were shown as a percentage of the NLCs;
(C-ii) With verapamil: the profile of SP cells decreased greatly. (C-iii) Without verapamil: SP cells were shown with low fluorescence in HCCs; (C-iv) With
verapamil: fluorescence of the SP cells fraction shifted to a higher level. (C-v) The percentages of SP cells in different groups are reflected in a column
chart. Original magnification, 2006(A, B-iii), 1006(A, B-iv, v, vi).
doi:10.1371/journal.pone.0023311.g001
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more slowly in SP cells than in both SSP cells and NSP cells
(P,0.01). The following percentages were observed: CD133
percentages in SP-NLCs, NSP-NLCs, SSP-NLCs, SP-HCCs,
NSP-HCCs and SSP-HCCs were 78.666.98, 3.460.33,
20.262.03, 80.567.86, 3.660.30 and 20.762.38, respectively;
EpCAM percentages in these subpopulations were 78.167.53,
3.560.28, 21.562.17, 80.368.12, 2.360.27 and 20.262.28,
respectively. During the proliferation period, both SP-NLCs and
SP-HCCs maintained the high expression of stem cell markers; in
contrast, both NSP-NLCs and NSP-HCCs gradually lost expres-
sion of the stem cell markers. These data suggest that SP cells are
similar to stem cells in their self-renewal capacity.
4. Differentiation of SP cells induced by HGF in vitro
Under induction conditions, each subpopulation generated
distinct outgrowths. Because NLCs should differentiate into
hepatocytes or biliary epithelial cells, we selected one mature
hepatic marker (ALB) and one biliary marker (CK-7) to identify
mature cells. Most SP-NLCs expanded into sheets of tightly
packed cells that displayed typical hepatocyte morphology and
were identified as ALB positive cells (66.965.34%). A portion of
the SP-NLCs differentiated into CK-7 positive cells (24.662.41%)
(Figure 3A). Although both NSP-NLCs and SSP-NLCs could also
generate ALB positive cells, only several CK-7 positive cells could
be found in induced SSP-NLCs, and no CK-7 positive cells were
found in induced NSP-NLCs (Figure 3A). These data indicate that
only SP-NLCs had a strong potential to differentiate into different
types of mature cells. Western blotting demonstrated that although
the cells generated by NSP-NLCs expressed higher ALB than the
cells from SP-NLCs and SSP-NLCs, daughters of SP-NLCs
expressed much higher levels of CK-7 than the daughters of SSP-
NLCs and NSP-NLCs (Figure 3C). In particular, CK-7 displayed
almost no expression in the daughters of NSP-NLCs (Figure 3C).
These data were concordant with the IF observations.
Because HCCs should differentiate into liver tumor cells, we
selected one hepatic tumor marker (AFP) and one biliary tumor
marker (CK-19) to identify mature cells. After induction, the
daughters of SP-HCCs, SSP-HCCs and NSP-HCCs displayed
heterogeneous, differentially expressed AFP. The percentages of
AFP positive cells in SP-HCCs, NSP-HCCs and SSP-HCCs were
87.868.65%, 65.865.24% and 71.566.13% (Figure 3B). Unfor-
tunately, none of the three types of HCCs could generate CK-19
positive cells (Figure 3B). These data indicate that HCCs had a
hepatocellular carcinoma origin. By western blotting, the expres-
sion of AFP in induced SP-HCCs was 2 times higher than that in
induced NSP-HCCs and 1.5 times higher than that in induced
SSP-HCCs. In contrast, CK-19 was not expressed in the
daughters of SP-HCCs, SSP-HCCs and NSP-HCCs (Figure 3D).
These data were concordant with the IF observations.
The daughter cells from SP-HCCs expressed much higher levels
of the early hepatic marker AFP and lower levels of the late
hepatic marker ALB than those of SP-NLCs (P,0.01). In one
word, compared to NSP cells, both SP cells showed more stem-like
properties (P,0.01).
5. SP-NLCs aided in treating injured livers
Before transplantation, we stained the membranes of SP-NLCs
(Figure 4A-i) and NSP-NLCs (Figure 4B-i) with red fluorescence
using the PKH26 cell linker dye. As the dye linked the membranes
of these cells, it was transferred from parent cell to the daughter
cell during the process of proliferation, which occurred for up to
ten generations. Before cell transplantation, the rats were severely
injured by CCl4 and 2/3 PH. Thirty days after transplantation of
the cells, the rats were sacrificed and the extent of liver repair was
examined. The livers of animals receiving SP-NLCs injection had
sharper edges and a smoother surface (Figure 4A-ii). In contrast,
after NSP-NLCs transplantation, the livers were hardly repaired
and exhibited a rough surface (Figure 4B-ii). By H&E staining, the
liver tissues of the rats receiving SP-NLCs injection (Figure 4A-iii)
showed fewer balloon-like morphological changes, less cell swelling
and more regular cell order than those receiving an injection of the
same number of NSP-NLCs (Figure 4B-iii). Under fluorescent
microscopy, cells labeled by red fluorescence could be observed in
SP-NLCs transplanted liver lobules (Figure 4A-iv), and branch-like
red fluorescence could be detected in the region near the portal
area of some lobules (Figure 4A-v). In contrast, few red cells could
be observed in either the general area (Figure 4B-iv) or in the
region near the portal area (Figure 4B-v) of NSP-injected liver
lobules. These results demonstrate that SP-NLCs were more
effectively involved in liver repair than NSP-NLCs.
Based on the grading criteria for red fluorescence in the liver
sections, we analyzed 40 sections of SP-NLCs-transplanted livers
and 40 sections of NSP-NLCs-injected livers. We summarized
these data in Table 2. Generally speaking, most SP-NLCs restored
liver sections displaying moderate or strong positive red fluores-
cence. In contrast, most NSP-NLCs restored liver sections
reflecting negative or weak positive red fluorescence. In short,
much more red fluorescence appeared in SP-NLCs-restored liver
sections than in NSP-NLCs injected liver sections (P,0.01).
6. SP-HCCs are tumorigenic in vivo
To test the tumorigenic ability of SP-HCCs and NSP-HCCs,
various numbers of cells were injected into mice. We counted the
number of tumors in each mouse, measured the size of each
tumor, checked for liver metastasis, and summarized those data in
Table 3. The xenograft tumors were found within nearly each
mouse injected with different numbers of SP-HCCs, including
those injected with as few as 1610
4 cells. In contrast, only more
than 1610
5 NSP-HCCs could generate tumors. As few as 1610
4
SP-HCCs could initiate tumors not only in subcutaneous tissues
(Figure 5A), but also in liver tissues (Figure 5B) of NOD/SCID
mice. Pathological analysis indicated that the tissues from the
subcutaneous regions (Figure 5C) and from the livers (Figure 5D)
were all hepatic carcinoma-derived. However, the same number of
NSP-HCCs (1610
4) could not generate tumors in subcutaneous
tissues (Figure 5E) or liver tissues (Figure 5F) of NOD/SCID mice.
Therefore, with the same number of cells, SP-HCCs caused more
tumors and much bigger tumors than NSP-HCCs (P,0.01). Most
importantly, liver metastasis was always present in each mouse
injected with SP-HCCs. However, obvious liver metastasis could
not be found in any mouse that had received the injection of NSP-
HCCs (Table 3).
7. Profile of miRNAs in SP-HCCs and SP-NLCs
The miRNA array indicated differential expression of 78
miRNAs in SP-HCCs compared to SP-NLCs (P,0.01)
(Figure 6A). Up-regulated miRNAs were found more frequently
(87.2%; 68 of 78) than down-regulated miRNAs (12.8%; 10 of 78).
The fold increase of over-expressed miRNAs varied from
2.00060.032 to 4.31960.312, while that of the down-regulated
miRNAs was from 2.61160.024 to 6.58060.409. The fold change
of down-regulated miRNAs was, on average, larger than that of
the over-expressed miRNAs. Cluster analysis of over-expressed
miRNAs (Figure S1A) and under-expressed miRNAs (Figure S1B)
indicated that some deregulated miRNAs might play their roles in
groups, such as up-regulated miR-10b and miR-21 and down-
regulated miR-200a* and miR-148b*.
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NLCs by QRT-PCR was as following (Figure 6B, C): miR-200a*
(24.27560.094), miR-148b* (22.08760.050), let-7i* (2.1266
0.072), miR-16 (2.22760.076), miR-34c-5p (2.82360.092), miR-
21 (3.17360.069) and miR-10b (4.64360.087). The expression
patterns of seven representative miRNAs detected by QRT-PCR
were highly concordant with the array data.
8. Targets of deregulated miRNAs
The proven targets of seven validated, deregulated miRNAs are
listed in Table 4. Among these targets, we detected the targets of miR-
200a* (the most down-regulated miRNA) in both SP cells. In contrast
to the miR-200a* expression, both targets ZEB1 and ZEB2 were
expressed at much higher levels in SP-HCCs than in SP-NLCs by
sQRT-PCR (Figure S2). The MiRanda miRBase uses a complemen-
tary type algorithm and the TargetScan uses a seed complementarity
type algorithm. Based on these two algorithms, the top 10 putative
targets for each deregulated miRNA were identified (Table S1).
Discussion
Cancer is widely accepted as a disease of stem cells because these
are the only cells that persist in the tissue for a sufficient length of
time to acquire the requisite number of genetic changes for
neoplastic development [34]. Many researchers have demonstrated
the existence of HCSCs in HCC tissues [1,2,3]. Accordingly, the
normal liver is an excellent source of HNSCs. In this study, we
successfully enriched both SP-HCCs and SP-NLCs. SP cells
Figure 4. The regenerative effects of transplanted cells in acutely injured rats. The membranes of (A-i) SP-NLCs and (B-i) NSP-NLCs were
successfully stained with PKH26 fluorescence. After the rats were severely damaged by CCl4 and a 2/3 PH, (A-ii) transplantation of SP-NLCs enhanced
liver repair (shown by a smooth surface), whereas (B-ii) the livers in the NSP-NLCs injected group still exhibit a rough surface. (A-iii) The H&E staining
of livers in the SP-NLCs transplanted group. (B-iii) The livers in the NSP-NLCs injected group were stained by H&E. (A-iv) After SP-NLCs transplantation,
many sporadic cells labeled by red fluorescence could be observed in the liver. (B-iv) However, minor red cells could be found in NSP-NLCs
transplanted liver (arrows). (A-v) Complete hepatic cord-like structure with red fluorescence could be detected in the region near the portal area of
the SP-NLCs restored liver (arrows). (B-v) Around the portal area, very weak red fluorescence in NSP-NLCs repaired liver was present (arrows). Original
magnification, 2006(A, B-i, iii, iv, v). (For a better interpretation of the colored figure, the reader is referred to the web version of the article).
doi:10.1371/journal.pone.0023311.g004
Figure 3. The induced differentiation of each subpopulation. (A) Through IF, ALB positive cells (green, nuclei in blue) and CK-7 positive cells
(green, nuclei in blue) were differentially produced by SP-NLCs, NSP-NLCs and SSP-NLCs. The percentages of ALB or CK-7 positive cells are shown in a
column chart. (B) In contrast, AFP positive cells could be found after SP-HCCs, NSP-HCCs and SSP-HCCs induction. The data are summarized in a
column chart. (C) By western blotting, fold differences in specific markers relative to GAPDH were analyzed in induced SP-NLCs, NSP-NLCs and SSP-
NLCs. (D) Western blotting results of tumor-specific markers in induced SP-HCCs, NSP-HCCs and SSP-HCCs. Original magnification, 2006(A, B). (For a
better interpretation of the colored figure, the reader is referred to the web version of the article).
doi:10.1371/journal.pone.0023311.g003
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normal development and cancer biology [16]. Thus, these cells
could provide a useful tool and a readily accessible source for stem
cellstudies in both normal and cancerous settings [35]. In this study,
both SP-NLCs and SP-HCCs were demonstrated to have a high
capacity for self-renewal, high expression of stem cell markers, and
multi-potency in generating different cell types. Therefore, these SP
cells were stem-like cells. SP cells can thus be considered an
appropriate source of stem cells [36], and comparative analysis of
the characteristics that distinguish SP-HCCs and SP-NLCs would
be expected to contribute to the understanding of HCC genesis.
Moreover, as efficient suppressors of gene expression, miRNAs are
expected to be involved in regulating the differences between SP-
HCCs and SP-NLCs.
We must emphasize how we obtained the related results. After
tumor was formed in F344 rats, we selected 4 rats for cell isolation.
That is to say, we separately isolated HCCs from each whole HCC
tissue of 4 DEN-induced rats and NLCs from each liver of 4 normal
rats. The subsequent experiments were performed using HCCs or
NLCs from single rat, and the results were statistically analyzed and
represented as Mean 6 Standard error. For example, we separately
isolated SP-HCCs from each kind of 4 HCCs, SP-NLCs from each
kind of 4 NLCs. The percentages of SP cells in the whole cell
population were then obtained by calculating the average of the
data from the 4 samples. Finally, for miRNA array, we used 4 SP-
NLCs as parallel controls and 4 SP-HCCs as parallel trials.
1. Differences between SP-HCCs and SP-NLCs in vitro and
in vivo
In this study, both SP-HCCs and SP-NLCs were demonstrated
to have stem-like properties by high expression of stem cell
Figure 5. The tumor formation capacity. The smallest number SP-HCCs could generate tumors (A) not only in subcutaneous tissues (B), but also
in the livers of NOD/SCID mice. Based on pathological analysis, (C) the subcutaneous tissues and (D) liver tissues underwent hepatic carcinoma
genesis. In contrast, the same number NSP-HCCs could not generate tumors in (E) subcutaneous tissues or liver tissues (F) of NOD/SCID mice. Original
magnification, 2006(C, D).
doi:10.1371/journal.pone.0023311.g005
Table 2. The percentages of red fluorescence in liver
sections.
Cell
subpopulation
Sample
number Red2 Red+ Red++ Red+++
SP-NLCs 40 060.00 260.27 2561.83 1361.21
NSP-NLCs
a 40 1060.84 2662.56 460.32 060.00
All results were viewed by three different researchers.
aNSP-NLCs vs. SP-NLCs, N=40, P,0.01.
doi:10.1371/journal.pone.0023311.t002
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PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23311Figure 6. Confirmation of deregulated miRNAs by miRNA array and QRT-PCR. (A) Sixty- eight miRNAs were demonstrated to be
differentially up-regulated and ten miRNAs were distinctly down-regulated using the miRNA array. (B) Five representative miRNAs displayed
consistent over-expression and (C) two representative miRNAs showed concordant under-expression by QRT-PCR. The error bar indicates the SEM.
doi:10.1371/journal.pone.0023311.g006
Table 3. The tumor formation of distinct typed cells in nude mice.
Cell subpopulations Tumor incidence Tumor diameter Metastasis incidence
SP-HCCs (1610
7) 4/4 +++ 4/4
SP-HCCs (1610
6) 4/4 ++ 4/4
SP-HCCs (1610
5) 4/4 ++ 4/4
SP-HCCs (1610
4) 4/4 + 4/4
NSP-HCCs (1610
7)
a 4/4 ++ 0/4
NSP-HCCs (1610
6)
b 3/4 + 0/4
NSP-HCCs (1610
5)
c 2/4 + 0/4
NSP-HCCs (1610
4)
d 0/4 2 0/4
‘‘Tumor incidence’’ indicates the average incidence of tumors in each mice (4 mice in each group, 4/4 means 4 tumors in 4 injection sites). ‘‘Tumor diameter’’ refers to
the average diameter of tumors in each group (2, no macroscopic tumor; +, ,0.2 cm; ++, 0.2–0.5 cm; +++, .0.5 cm). ‘‘Metastasis incidence’’ means the average
incidence of the liver neoplasia appeared in each group (4/4 means 4 liver neoplasias found in 4 mice). All results were independently viewed by three different
researchers.
a–dNSP-HCCs vs. SP-HCCs (the same number), P,0.01.
doi:10.1371/journal.pone.0023311.t003
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could not be distinguished from each other by morphology.
Although both SP-NLCs and SP-HCCs could rapidly proliferate,
these cells differentiated into distinct lineages. Under induction
conditions, both SP cells could be induced to differentiate into
mature cells. SP-NLCs could differentiate into many ALB positive
cells and a few CK-7 positive cells; in contrast, SP-HCCs could
only generate AFP positive cells. These differences would result in
totally different consequences in vivo, as described below. When the
rats were severely injured by CCl4 and a 2/3 PH, SP-NLCs could
aid in improving the injured livers both in terms of morphology
and function. This rescue was through permanent implantation
into the liver and differentiation into functional cells, which was
concordant with previous studies [37]. In contrast, SP-HCCs had
a high ability to form tumors in NOD/SCID mice, and even as
few as 1610
4 SP-HCCs were enough to initiate HCC, which is
similar to another study’s findings [38]. Upon subcutaneous
injection, SP-HCCs could migrate to the liver and caused
neoplasias, even with only 1610
4 cells. However, we could not
find obvious liver metastasis in any mouse that had received an
injection of NSP-HCCs. These data indicate that SP-HCCs were
more malignant and invasive, which may be related to their
stemness. Both findings revealed that SP-NLCs were more
differentiated, which was useful for the regeneration of injured
livers. In contrast, SP-HCCs were more immature, suggesting that
stemness may be related to invasiveness. Combining the above
results, SP cells appear to serve a central role in liver regeneration
and HCC genesis.
2. Deregulation of miRNAs in SP-HCCs and SP-NLCs
Although both SP-HCCs and SP-NLCs shared some common
characteristics of stem cells, they differentiated in totally different
directions that resulted in completely opposite consequences.
Changes in multiple genes have been proposed to account for this
process. Through ex vivo genetic manipulation, HNSCs can
successfully generate liver carcinomas in transplanted mice [39].
During this process, mature miRNAs engage in either degradation
of the target mRNA or translational repression [40]. Although the
deregulated miRNAs in HCC have been detected by different
researchers, the expression profile of miRNAs in HCSCs is still not
understood. Thus, the analysis of miRNA expression profiles in
SP-HCCs and SP-NLCs would greatly contribute to understand-
ing HCSC genesis. For the miRNA array, we used 4 SP-NLCs as
parallel controls and 4 SP-HCCs as parallel trials. Similar to the
findings from carcinomas of the lung [41], ovary [42] and liver
[29], our data on SP-HCCs revealed a higher frequency of
miRNA over-expression than under-expression.
In this study, miR-10b, miR-21 and miR-92b were frequently
over-expressed. Accordingly, these miRNAs have also been
reported to have increased expression in the majority of cancer
types examined [19,41,43,44,45], including HCC [46], breast
[47], lung [48], colon [49] and gastric cancers [50]. In this study,
miR-92b (one member of the miR-17-92 family) was highly
expressed in SP-HCCs. This miRNA has been shown to control
the G1/S checkpoint gene p57 and, as a result, promotes stem cell
transition from G1-phase to S-phase [51]. Because the G1/S
restriction is largely absent in SP cells, these cell-cycle controlling
miRNAs may be responsible for enabling SP cells to rapidly move
through G1 phase, enter S phase and rapidly proliferate. There
are two miRNAs that are possibly related to the invasive nature of
SP-HCCs. MiR-21 has been demonstrated to target PTEN [52]
and results in the further modulation of HCC cell migration and
invasion. This effect is believed to occur via modulation of the
phosphorylation of focal adhesion kinase [52] and the expression
of matrix metalloproteinases 2 and 9 [52]. Most importantly, miR-
10b, the second most over-expressed miRNA in SP-HCCs, has
been found to be highly expressed in metastatic breast cancer cells
and has been shown to positively regulate cell migration and
invasion [53]. MiR-10b inhibits the synthesis of the HOXD10
protein and permits the expression of the pro-metastatic gene
product RHOC, which in turn favors cancer cell migration and
invasion [53]. In short, based on previous studies, we propose that
the greatly up-regulated miRNAs may contribute to the rapid
proliferation, migration and invasion of SP-HCCs.
Among the moderately up-regulated miRNAs, miR-451 and
miR-181a have been well studied. MiR-451, which was over-
expressed in SP-HCCs, is involved in activating the expression of
P-glycoprotein (P-gp), the MDR1 gene product that confers the SP
phenotype [54]. In addition, miR-181a has been demonstrated to
be responsible for the genesis of human liver cancer stem/
progenitor cells [55]. Thus, these two miRNAs may contribute to
the stem cell-like properties of SP-HCCs. However, the slightly up-
regulated miR-16, miR-34c-3p and let-7i* miRNAs in this study
have been demonstrated to be down-regulated in other cancer
settings [56,57,58]. One reason for this discrepancy may result
from differences in the compared objects. We compared normal
stem cells to CSCs, while previous researchers have compared
mature cancer tissues/cells with normal tissues/cells. In addition,
the above three miRNAs may not be responsible for the
differences between SP-NLCs and SP-HCCs. Moreover, the
Table 4. The proven targets of validated miRNAs.
MicroRNAs Proven targets
Increased expression .2-fold
miR-10b HOXD10 [62], Tiam1 [63], PPAR-alpha [64]
miR-21 PTEN [65], Caspase-3 [66], PDCD4 [67]
miR-34c-3p c-Met [57], c-Myc [68], E2F3 [69], BCL-2 [69]
miR-16 BCL2 [56], MCL1 [70], CCND1 [70], WNT3A [70], HMGA1 [71], Caprin-1 [71], Bmi-1 [72], G(1) cyclins [73]
let-7i* TLR4 [74], E-cadherin [58], ZEB1 [58]
Decreased expression ,0.5-fold
miR-200a* ZEB1 [75], ZEB2 [76], CTNNB1 [77], E-cadherin [76]
miR-148b* None found
doi:10.1371/journal.pone.0023311.t004
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much smaller than that in other studies. Overall, we propose that
these miRNAs may be marginally deregulated.
Two important miRNAs that were down-regulated in SP-
HCCs, miR-200a* and miR-148b*, have been described in HCC
tissues [26] and ovarian cancers [47]. Recent findings have
associated miR-200a* with stem cell maintenance and suggest a
connection between the epithelial-to-mesenchymal transition
(EMT) and stem cell formation. A part of tumor progression can
be viewed as a continuum of progressive dedifferentiation (EMT)
with a cell at the endpoint that has stem cell-like properties [20].
The ZEB-miR-200 feedback loop has been demonstrated to link
EMT activation and the maintenance of stemness by suppressing
stemness-inhibiting miRNAs and acting as a promoter of mobile,
migrating CSCs [59]. In this study, the targets of miR-200a*,
ZEB1 and ZEB2 were both expressed at much higher levels in SP-
HCCs than in SP-NLCs. These data indicate that the greatly
down-regulated miR-200a* may promote malignant transforma-
tion of SP-NLCs and force SP-HCCs to become more metastatic.
Overall, some miRNAs are common to both NSCs and CSCs
and may be required to maintain stemness [60]. However, some
miRNAs that are differentially expressed between NSCs and CSCs
may contribute to the distinct in vivo consequences caused by these
two types of stem-like cells. Therefore, therapies that target the
deregulation of miRNAs could be powerful tools for correcting the
deregulation of CSCs [61].
Conclusions
This study was the first to analyze the differences between SP-
NLCs and SP-HCCs. Both SP cells were demonstrated to be stem-
like cells. However, SP-NLCs are more regenerative, whereas SP-
HCCs are more tumor-formative in vivo. Furthermore, given that
the deregulation of miRNAs in SP-HCCs is an early event in the
process of HCC genesis, this work will undoubtedly provide novel
insights into the intricate relationship between miRNAs, CSCs
and HCC.
Limitations
Although we proposed that these deregulated miRNAs may
contribute to the observed differences between SP-HCCs and SP-
NLCs, the exact roles of these miRNAs in the process of HCSCs
genesis must be verified. Several important up-regulated miRNAs
and down-regulated miRNAs were found in SP-HCCs. We are
planning to investigate these specific miRNAs, probe for their
targets and eventually reveal the mechanisms contributing to
miRNA-mediated effects on HCSC genesis.
Supporting Information
Figure S1 Cluster analysis of deregulated miRNAs. (A)
Cluster analysis of over-expressed miRNAs from profiling. (B)
Cluster analysis of under-expressed miRNAs from profiling. Red
depicts high expression levels, whereas green and black corre-
sponded to low expression levels and non-varied signals,
respectively.
(TIF)
Figure S2 The target analysis of miR-200a*. By sQRT-
PCR, both target genes ZEB1 and ZEB2 were expressed at much
higher levels in SP-HCCs than in SP-NLCs.
(TIF)
Table S1 The predicted targets for deregulated miR-
NAs. Based on two different algorithms, the top 10 putative
targets for each deregulated miRNA were identified and
summarized into a table.
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